Management and control of type 2 diabetes mellitus in Lebanon: Results from the International Diabetes Management Practices Study Wave 6

Table 3 Screening of diabetes-related complications in patients with diabetes mellitus

Screening for any diabetes-related complication, n (%)
Yes	553 (97.9)
No	12 (2.1)
Screening for cardiovascular disease
At least one time during the past year	376 (76.9)
Never	113 (23.1)
Eye screening
At least one time during the past year	295 (65.7)
Never	154 (34.3)
Number of eye screening, mean (SD)	1.20 (0.57)
Screening for nerve damage
At least one time during the past year	232 (53.8)
Never	199 (46.2)
Number of screening for nerve damage, mean ± SD	1.75 ± 1.01
Screening for kidney damage
At least one time during the past year	425 (82.5)
Never	90 (17.5)
Number of screening for kidney damage, mean ± SD	1.87 ± 1.02
Screening for foot examination
At least one time during the past year	297 (63.9)
Never	168 (36.1)
Number of screening for foot examination, mean ± SD	1.90 ± 1.08
Screening for blood lipid control
At least one time during the past year	496 (94.8)
Never	27 (5.2)
Number of screening for blood lipid control, mean ± SD	2.06 ± 1.04
Screening for blood pressure control n (%)
At least one time during the past year	286 (86.1)
Never	46 (13.9)
Number of screening for blood pressure control, mean ± SD	2.57 ± 1.17